- Home
- GNLX vs KTF Comparison
GNLX vs KTF Comparison
Compare GNLX & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- KTF
- Stock Information
- Founded
- GNLX 2001
- KTF 1988
- Country
- GNLX United States
- KTF United States
- Employees
- GNLX N/A
- KTF N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- KTF Finance Companies
- Sector
- GNLX Health Care
- KTF Finance
- Exchange
- GNLX Nasdaq
- KTF Nasdaq
- Market Cap
- GNLX 103.6M
- KTF 384.3M
- IPO Year
- GNLX 2023
- KTF N/A
- Fundamental
- Price
- GNLX $2.27
- KTF $9.47
- Analyst Decision
- GNLX Strong Buy
- KTF
- Analyst Count
- GNLX 4
- KTF 0
- Target Price
- GNLX $18.25
- KTF N/A
- AVG Volume (30 Days)
- GNLX 142.7K
- KTF 103.3K
- Earning Date
- GNLX 11-14-2024
- KTF 01-01-0001
- Dividend Yield
- GNLX N/A
- KTF 3.54%
- EPS Growth
- GNLX N/A
- KTF N/A
- EPS
- GNLX N/A
- KTF 0.39
- Revenue
- GNLX $8,000.00
- KTF N/A
- Revenue This Year
- GNLX N/A
- KTF N/A
- Revenue Next Year
- GNLX N/A
- KTF N/A
- P/E Ratio
- GNLX N/A
- KTF $23.10
- Revenue Growth
- GNLX N/A
- KTF N/A
- 52 Week Low
- GNLX $1.60
- KTF $7.40
- 52 Week High
- GNLX $16.60
- KTF $9.12
- Technical
- Relative Strength Index (RSI)
- GNLX 38.68
- KTF 21.65
- Support Level
- GNLX $2.13
- KTF $9.95
- Resistance Level
- GNLX $2.80
- KTF $10.10
- Average True Range (ATR)
- GNLX 0.20
- KTF 0.09
- MACD
- GNLX -0.04
- KTF -0.06
- Stochastic Oscillator
- GNLX 14.21
- KTF 12.50
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-end, diversified investment management company. The investment objective is to provide high current income exempt from federal income tax by investing in a diversified portfolio of investment-grade tax-exempt securities. Its products include ETFs, Mutual Funds, Closed-End-Funds, Money Market Funds, and others.